UBS AG - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 115 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$1,000
-98.4%
32
-98.9%
0.00%
Q2 2014$61,000
-3.2%
2,946
-10.6%
0.00%
Q1 2014$63,000
+103.2%
3,297
+161.3%
0.00%
Q4 2013$31,000
+1450.0%
1,262
+1079.4%
0.00%
Q3 2013$2,000
-60.0%
107
-49.5%
0.00%
Q2 2013$5,0002120.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders